134 related articles for article (PubMed ID: 7857388)
1. Lipoprotein (a): implication in atherothrombosis.
Chapman MJ; Huby T; Nigon F; Thillet J
Atherosclerosis; 1994 Oct; 110 Suppl():S69-75. PubMed ID: 7857388
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fibrinolysis by lipoprotein(a).
Anglés-Cano E; de la Peña Díaz A; Loyau S
Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein Lp(a) and atherothrombotic disease.
de la Peña-Díaz A; Izaguirre-Avila R; Anglés-Cano E
Arch Med Res; 2000; 31(4):353-9. PubMed ID: 11068075
[TBL] [Abstract][Full Text] [Related]
4. Functional approach to investigate Lp(a) in ischaemic heart and cerebral diseases.
de la Peña-Díaz A; Cardoso-Saldaña G; Zamora-González J; Barinagarrementeria F; Izaguirre R; Loyau S; Anglés-Cano E
Eur J Clin Invest; 2003 Feb; 33(2):99-105. PubMed ID: 12588282
[TBL] [Abstract][Full Text] [Related]
5. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
Hervio L; Chapman MJ; Thillet J; Loyau S; Anglés-Cano E
Blood; 1993 Jul; 82(2):392-7. PubMed ID: 8329699
[TBL] [Abstract][Full Text] [Related]
6. Beyond fibrinolysis: The confounding role of Lp(a) in thrombosis.
Boffa MB
Atherosclerosis; 2022 May; 349():72-81. PubMed ID: 35606079
[TBL] [Abstract][Full Text] [Related]
7. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
[TBL] [Abstract][Full Text] [Related]
8. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin.
Hervio L; Girard-Globa A; Durlach V; Anglés-Cano E
Eur J Clin Invest; 1996 May; 26(5):411-7. PubMed ID: 8796369
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein(a) promotes smooth muscle cell proliferation and dedifferentiation in atherosclerotic lesions of human apo(a) transgenic rabbits.
Ichikawa T; Unoki H; Sun H; Shimoyamada H; Marcovina S; Shikama H; Watanabe T; Fan J
Am J Pathol; 2002 Jan; 160(1):227-36. PubMed ID: 11786416
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein Lp(a) excess and coronary heart disease.
Stein JH; Rosenson RS
Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
[TBL] [Abstract][Full Text] [Related]
11. Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery.
Lindén T; Taddei-Peters W; Wilhelmsen L; Herlitz J; Karlsson T; Ullström C; Wiklund O
Atherosclerosis; 1998 Mar; 137(1):175-86. PubMed ID: 9568750
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside.
Marcovina SM; Koschinsky ML
Curr Opin Lipidol; 2003 Aug; 14(4):361-6. PubMed ID: 12865733
[TBL] [Abstract][Full Text] [Related]
13. Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.
Gaw A; Docherty G; Brown EA; Ford I
Atherosclerosis; 1999 Apr; 143(2):445-50. PubMed ID: 10217375
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers?
Koschinsky ML
Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772
[TBL] [Abstract][Full Text] [Related]
15. Relationship between plasma phospholipid transfer protein activity and HDL subclasses among patients with low HDL and cardiovascular disease.
Cheung MC; Wolfbauer G; Brown BG; Albers JJ
Atherosclerosis; 1999 Jan; 142(1):201-5. PubMed ID: 9920522
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process.
Anglés-Cano E
Braz J Med Biol Res; 1997 Nov; 30(11):1271-80. PubMed ID: 9532233
[TBL] [Abstract][Full Text] [Related]
17. Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
Nardulli M; Durlach V; Pepe G; Anglés-Cano E
Thromb Haemost; 2005 Jul; 94(1):75-81. PubMed ID: 16113787
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.
Ishikawa S; Deguchi T; Hara K; Takuma S; Kayaba K; Tsutsumi A; Kario K; Igarashi M
J Epidemiol; 1999 Feb; 9(1):32-9. PubMed ID: 10098351
[TBL] [Abstract][Full Text] [Related]
19. [Lipoprotein(a): characteristics of a special lipoprotein and its potential clinical significance].
Armstrong VW
Ther Umsch; 1990 Jun; 47(6):475-81. PubMed ID: 2142832
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plasma lipoprotein (a), apolipoprotein (a) phenotypes, and other coronary heart disease risk factors in a Melbourne South Asian population.
Xiong ZW; Wahlqvist ML; Ibiebele TI; Biegler BM; Balazs ND; Xiong DW; Lim YL
Clin Biochem; 2004 Apr; 37(4):305-11. PubMed ID: 15003733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
